# Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

Study · id `cardio:ct-nct01566175` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01566175](<https://clinicaltrials.gov/study/NCT01566175>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01566175

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01566175. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08-30 (actual); primary completion 2030-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01566175, source copy `cardio:ctgov-nct01566175-2022-02-02`, retrieved 2026-11-18)
- Started: 2011-08-30 (actual) (ClinicalTrials.gov record NCT01566175, source copy `cardio:ctgov-nct01566175-2022-02-02`, retrieved 2026-11-18)
- Primary completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT01566175, source copy `cardio:ctgov-nct01566175-2022-02-02`, retrieved 2026-11-18)
- Completion: 2031-12-31 (anticipated) (ClinicalTrials.gov record NCT01566175, source copy `cardio:ctgov-nct01566175-2022-02-02`, retrieved 2026-11-18)
- Countries: Israel (ClinicalTrials.gov record NCT01566175, source copy `cardio:ctgov-nct01566175-2022-02-02`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01566175-2022-02-02`, retrieved 2026-11-18)

## The registry's words

- Brief title: Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
- Acronym: Reducer
- Condition: Refractory Angina
- Intervention (Device): Neovac coronary sinus reducer
- Lead sponsor: Tel-Aviv Sourasky Medical Center
- Lead sponsor class: OTHER\_GOV
- Collaborator: Shockwave Medical, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry lists this organization as the lead sponsor: Tel-Aviv Sourasky Medical Center (`cardio:org-tel-aviv-sourasky-medical-center`)
- Registry lists this organization as a collaborator: Shockwave Medical, Inc. (`cardio:org-shockwave-medical-inc`)

## Provenance

Content hash: 1f2accefee7bbae698afe0b2a167d1177fd3f1e8c5b0428fffb042ee238b777a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
